These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8433007)

  • 41. A comprehensive study of oculocutaneous albinism type 1 reveals three previously unidentified alleles on the TYR gene.
    Lin YY; Wei AH; He X; Zhou ZY; Lian S; Zhu W
    Eur J Dermatol; 2014; 24(2):168-73. PubMed ID: 24721949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism.
    Spritz RA; Strunk KM; Hsieh CL; Sekhon GS; Francke U
    Am J Hum Genet; 1991 Feb; 48(2):318-24. PubMed ID: 1899321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ocular findings in patients with oculocutaneous albinism type ia with G47D tyrosinase gene mutation in Puerto Rico: a case report.
    Rodríguez-Agramonte F; Izquierdo NJ; Cadilla C
    Bol Asoc Med P R; 2013; 105(2):62-4. PubMed ID: 23882993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism.
    Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H
    J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A splicing mutation of the tyrosinase gene causes yellow oculocutaneous albinism in a Japanese patient with a pigmented phenotype.
    Matsunaga J; Dakeishi-Hara M; Tanita M; Nindl M; Nagata Y; Nakamura E; Miyamura Y; Kikuchi K; Furue M; Tomita Y
    Dermatology; 1999; 199(2):124-9. PubMed ID: 10559577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of tyrosinase mutations associated with tyrosinase-related oculocutaneous albinism (OCA1).
    Oetting WS; King RA
    Pigment Cell Res; 1994 Oct; 7(5):285-90. PubMed ID: 7886000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation.
    Toyofuku K; Wada I; Spritz RA; Hearing VJ
    Biochem J; 2001 Apr; 355(Pt 2):259-69. PubMed ID: 11284711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphic sequences of the tyrosinase gene: allele analysis on 16 OCA1 patients in Japan indicate that three polymorphic sequences in the tyrosinase gene promoter could be powerful markers for indirect gene diagnosis.
    Tanita M; Matsunaga J; Miyamura Y; Dakeishi M; Nakamura E; Kono M; Shimizu H; Tagami H; Tomita Y
    J Hum Genet; 2002; 47(1):1-6. PubMed ID: 11829136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Genetics of oculocutaneous albinism].
    Zühlke C; Stell A; Käsmann-Kellner B
    Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular basis of oculocutaneous albinism.
    Oetting WS; King RA
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):131S-136S. PubMed ID: 7963676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2).
    Lee ST; Nicholls RD; Schnur RE; Guida LC; Lu-Kuo J; Spinner NB; Zackai EH; Spritz RA
    Hum Mol Genet; 1994 Nov; 3(11):2047-51. PubMed ID: 7874125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism.
    Giebel LB; Strunk KM; King RA; Hanifin JM; Spritz RA
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3255-8. PubMed ID: 1970634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A single base insertion in the putative transmembrane domain of the tyrosinase gene as a cause for tyrosinase-negative oculocutaneous albinism.
    Chintamaneni CD; Halaban R; Kobayashi Y; Witkop CJ; Kwon BS
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5272-6. PubMed ID: 1711223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutants.
    Halaban R; Cheng E; Hebert DN
    J Invest Dermatol; 2002 Aug; 119(2):481-8. PubMed ID: 12190874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutation analysis of the tyrosinase gene in oculocutaneous albinism.
    Camand O; Marchant D; Boutboul S; Péquignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M
    Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation.
    Oetting WS
    Pigment Cell Res; 2000 Oct; 13(5):320-5. PubMed ID: 11041207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Higher prevalence of OCA1 in an ethnic group of eastern India is due to a founder mutation in the tyrosinase gene.
    Chaki M; Mukhopadhyay A; Chatterjee S; Das M; Samanta S; Ray K
    Mol Vis; 2005 Jul; 11():531-4. PubMed ID: 16056219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hairbulb tyrosinase activity in oculocutaneous albinism: suggestions for pathway control and block location.
    King RA; Olds DP
    Am J Med Genet; 1985 Jan; 20(1):49-55. PubMed ID: 3918447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two novel tyrosinase (TYR) gene mutations with pathogenic impact on oculocutaneous albinism type 1 (OCA1).
    Ghodsinejad Kalahroudi V; Kamalidehghan B; Arasteh Kani A; Aryani O; Tondar M; Ahmadipour F; Chung LY; Houshmand M
    PLoS One; 2014; 9(9):e106656. PubMed ID: 25216246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.
    Gershoni-Baruch R; Rosenmann A; Droetto S; Holmes S; Tripathi RK; Spritz RA
    Am J Hum Genet; 1994 Apr; 54(4):586-94. PubMed ID: 8128955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.